These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38135030)

  • 41. Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.
    Compher C; Boullata JI; Pickett-Blakely O; Schiavone P; Stoner N; Kinosian BP
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1183-1190. PubMed ID: 26111832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.
    Armstrong D; Forbes A; Jeppesen PB; Lee HM; Nagy P; Seidner DL
    Clin Nutr; 2020 Jun; 39(6):1774-1777. PubMed ID: 31522784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding short bowel syndrome: Current status and future perspectives.
    Massironi S; Cavalcoli F; Rausa E; Invernizzi P; Braga M; Vecchi M
    Dig Liver Dis; 2020 Mar; 52(3):253-261. PubMed ID: 31892505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support.
    Chiba M; Masumoto K; Kaji T; Matsuura T; Morii M; Fagbemi A; Hill S; Pakarinen MP; Protheroe S; Urs A; Chen ST; Sakui S; Udagawa E; Wada M
    J Pediatr Gastroenterol Nutr; 2023 Sep; 77(3):339-346. PubMed ID: 37364133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
    Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
    Kochar B; Herfarth HH
    Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study.
    Blüthner E; Pape UF; Tacke F; Greif S
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.
    Gondolesi GE; Pape UF; Mason JB; Allard JP; Pironi L; Casas MNV; Schwartz LK; Joly F; Gabriel A; Sabrdaran S; Zhang P; Kohl-Sobania M; Huang YW; Jeppesen PB
    Nutrients; 2024 Aug; 16(15):. PubMed ID: 39125394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Teduglutide improves liver chemistries in short bowel syndrome-associated intestinal failure: Post hoc analysis.
    Micic D; Robinson I; Kidd T; Terreri B; Raphael BP
    Nutr Clin Pract; 2024 Jun; 39(3):634-640. PubMed ID: 38491966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
    Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
    Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure.
    O'Keefe SJ; Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):815-23.e1-3. PubMed ID: 23333663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.
    Tappenden KA; Edelman J; Joelsson B
    J Clin Gastroenterol; 2013 Aug; 47(7):602-7. PubMed ID: 23426461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetics and exposure-response analyses of teduglutide in adult and pediatric patients with short bowel syndrome.
    Marier JF; Jomphe C; Peyret T; Wang Y
    Clin Transl Sci; 2021 Nov; 14(6):2497-2509. PubMed ID: 34402197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive nutritional assessment in short bowel syndrome with chronic renal failure on teduglutide therapy: A case report.
    Borioli V; Cereda E; Lobascio F; Mengoli C; Caraccia M; Pagani A; Aronico N; Pedrazzoli P; Di Sabatino A; Caccialanza R
    Nutrition; 2020 May; 73():110720. PubMed ID: 32088500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interdisciplinary management of infantile short bowel syndrome: resource consumption, growth, and nutrition.
    Olieman JF; Poley MJ; Gischler SJ; Penning C; Escher JC; van den Hoonaard TL; van Goudoever JB; Bax NM; Tibboel D; IJsselstijn H
    J Pediatr Surg; 2010 Mar; 45(3):490-8. PubMed ID: 20223310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical improvement following home parenteral nutrition in pediatric patients with intestinal failure.
    Tung YC; Ni YH; Lai HS; Hsieh DY; Chang MH
    J Formos Med Assoc; 2006 May; 105(5):399-403. PubMed ID: 16638650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
    Seidner DL; Gabe SM; Lee HM; Olivier C; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):697-702. PubMed ID: 31423614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure.
    Fifi A; Raphael BP; Terreri B; Uddin S; Kaufman SS
    J Pediatr Gastroenterol Nutr; 2023 Nov; 77(5):666-671. PubMed ID: 37889619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical, social, and economic impacts of home parenteral nutrition dependence in short bowel syndrome.
    Winkler MF; Smith CE
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):32S-37S. PubMed ID: 24418898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.